147 related articles for article (PubMed ID: 23730212)
1. Control of both myeloid cell infiltration and angiogenesis by CCR1 promotes liver cancer metastasis development in mice.
Rodero MP; Auvynet C; Poupel L; Combadière B; Combadière C
Neoplasia; 2013 Jun; 15(6):641-8. PubMed ID: 23730212
[TBL] [Abstract][Full Text] [Related]
2. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
[TBL] [Abstract][Full Text] [Related]
3. Disruption of CCR1-mediated myeloid cell accumulation suppresses colorectal cancer progression in mice.
Kiyasu Y; Kawada K; Hirai H; Ogawa R; Hanada K; Masui H; Nishikawa G; Yamamoto T; Mizuno R; Itatani Y; Kai M; Taketo MM; Sakai Y
Cancer Lett; 2020 Sep; 487():53-62. PubMed ID: 32473241
[TBL] [Abstract][Full Text] [Related]
4. CCR1-mediated accumulation of myeloid cells in the liver microenvironment promoting mouse colon cancer metastasis.
Hirai H; Fujishita T; Kurimoto K; Miyachi H; Kitano S; Inamoto S; Itatani Y; Saitou M; Maekawa T; Taketo MM
Clin Exp Metastasis; 2014 Dec; 31(8):977-89. PubMed ID: 25326065
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of chemokine (C-C motif) receptor 1 (CCR1) suppresses colon cancer liver metastasis by blocking accumulation of immature myeloid cells in a mouse model.
Kitamura T; Fujishita T; Loetscher P; Revesz L; Hashida H; Kizaka-Kondoh S; Aoki M; Taketo MM
Proc Natl Acad Sci U S A; 2010 Jul; 107(29):13063-8. PubMed ID: 20616008
[TBL] [Abstract][Full Text] [Related]
6. Loss of SMAD4 Promotes Colorectal Cancer Progression by Accumulation of Myeloid-Derived Suppressor Cells through the CCL15-CCR1 Chemokine Axis.
Inamoto S; Itatani Y; Yamamoto T; Minamiguchi S; Hirai H; Iwamoto M; Hasegawa S; Taketo MM; Sakai Y; Kawada K
Clin Cancer Res; 2016 Jan; 22(2):492-501. PubMed ID: 26341919
[TBL] [Abstract][Full Text] [Related]
7. CCR1 and CCR5 mediate cancer-induced myelopoiesis and differentiation of myeloid cells in the tumor.
Zilio S; Bicciato S; Weed D; Serafini P
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35064009
[TBL] [Abstract][Full Text] [Related]
8. CCR1 plays a critical role in modulating pain through hematopoietic and non-hematopoietic cells.
Lewis ND; Muthukumarana A; Fogal SE; Corradini L; Stefanopoulos DE; Adusumalli P; Pelletier J; Panzenbeck M; Berg K; Canfield M; Cook BN; Razavi H; Kuzmich D; Anderson S; Allard D; Harrison P; Grimaldi C; Souza D; Harcken C; Fryer RM; Modis LK; Brown ML
PLoS One; 2014; 9(8):e105883. PubMed ID: 25170619
[TBL] [Abstract][Full Text] [Related]
9. Essential contribution of a chemokine, CCL3, and its receptor, CCR1, to hepatocellular carcinoma progression.
Yang X; Lu P; Fujii C; Nakamoto Y; Gao JL; Kaneko S; Murphy PM; Mukaida N
Int J Cancer; 2006 Apr; 118(8):1869-76. PubMed ID: 16284949
[TBL] [Abstract][Full Text] [Related]
10. Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis.
Yamamoto T; Kawada K; Itatani Y; Inamoto S; Okamura R; Iwamoto M; Miyamoto E; Chen-Yoshikawa TF; Hirai H; Hasegawa S; Date H; Taketo MM; Sakai Y
Clin Cancer Res; 2017 Feb; 23(3):833-844. PubMed ID: 27492974
[TBL] [Abstract][Full Text] [Related]
11. CCR1 and CCR5 promote hepatic fibrosis in mice.
Seki E; De Minicis S; Gwak GY; Kluwe J; Inokuchi S; Bursill CA; Llovet JM; Brenner DA; Schwabe RF
J Clin Invest; 2009 Jul; 119(7):1858-70. PubMed ID: 19603542
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor activity by dual blockade of CCR1 and CXCR2 expressed on myeloid cells within the tumor microenvironment.
Masui H; Kawada K; Itatani Y; Hirai H; Nakanishi Y; Kiyasu Y; Hanada K; Okamoto M; Hirata W; Nishikawa Y; Sugimoto N; Tamura T; Sakai Y; Obama K
Br J Cancer; 2024 May; ():. PubMed ID: 38750114
[TBL] [Abstract][Full Text] [Related]
13. Tumor cell apoptosis induces tumor-specific immunity in a CC chemokine receptor 1- and 5-dependent manner in mice.
Iida N; Nakamoto Y; Baba T; Kakinoki K; Li YY; Wu Y; Matsushima K; Kaneko S; Mukaida N
J Leukoc Biol; 2008 Oct; 84(4):1001-10. PubMed ID: 18644849
[TBL] [Abstract][Full Text] [Related]
14. Chemokine receptor CCR1 disruption limits renal damage in a murine model of hemolytic uremic syndrome.
Ramos MV; Auvynet C; Poupel L; Rodero M; Mejias MP; Panek CA; Vanzulli S; Combadiere C; Palermo M
Am J Pathol; 2012 Mar; 180(3):1040-1048. PubMed ID: 22203055
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of chemokine receptor CCR1 causes osteopenia due to impaired functions of osteoclasts and osteoblasts.
Hoshino A; Iimura T; Ueha S; Hanada S; Maruoka Y; Mayahara M; Suzuki K; Imai T; Ito M; Manome Y; Yasuhara M; Kirino T; Yamaguchi A; Matsushima K; Yamamoto K
J Biol Chem; 2010 Sep; 285(37):28826-37. PubMed ID: 20571024
[TBL] [Abstract][Full Text] [Related]
16. SMAD4-deficient intestinal tumors recruit CCR1+ myeloid cells that promote invasion.
Kitamura T; Kometani K; Hashida H; Matsunaga A; Miyoshi H; Hosogi H; Aoki M; Oshima M; Hattori M; Takabayashi A; Minato N; Taketo MM
Nat Genet; 2007 Apr; 39(4):467-75. PubMed ID: 17369830
[TBL] [Abstract][Full Text] [Related]
17. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model.
Menu E; De Leenheer E; De Raeve H; Coulton L; Imanishi T; Miyashita K; Van Valckenborgh E; Van Riet I; Van Camp B; Horuk R; Croucher P; Vanderkerken K
Clin Exp Metastasis; 2006; 23(5-6):291-300. PubMed ID: 17086356
[TBL] [Abstract][Full Text] [Related]
18. [Effect of CCR1 gene overexpression on the migration of bone marrow - derived mesenchymal stem cells towards hepatocellular carcinoma].
Gao Y; Huang XL; Zhang L; Deng L; Yin AH; Sun BC; Lu S
Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):354-359. PubMed ID: 28763842
[No Abstract] [Full Text] [Related]
19. CCL9/CCR1 induces myeloid‑derived suppressor cell recruitment to the spleen in a murine H22 orthotopic hepatoma model.
Li B; Zhang S; Huang N; Chen H; Wang P; Yang J; Li Z
Oncol Rep; 2019 Jan; 41(1):608-618. PubMed ID: 30365155
[TBL] [Abstract][Full Text] [Related]
20. CCR1 inhibition ameliorates the progression of lupus nephritis in NZB/W mice.
Bignon A; Gaudin F; Hémon P; Tharinger H; Mayol K; Walzer T; Loetscher P; Peuchmaur M; Berrebi D; Balabanian K
J Immunol; 2014 Feb; 192(3):886-96. PubMed ID: 24367031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
